Search results
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 2 weeks agoThis overlap should minimize the incremental costs associated with launching cabozantinib for prostate cancer and neuroendocrine tumors. Q: What factors are influencing the ...
JD Supra: New CMS Informed Consent Guidance for Sensitive Examinations of Unconscious Patients
JD Supra· 1 day ago...sensitive examinations or invasive procedures for educational and training purposes on patients outside medically necessary procedures, including pelvic, breast, prostate, or rectal examinations, and particularly on patients under anesthesia, first obtain and document the patients’ informed...
Q1 2024 Exelixis Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 week agoThis increase in gross to net deductions in the first quarter of 2024 is primarily related to higher Medicare Part D and PHS expenses. Historically, we ...
Mineral Community Hospital expands offerings
Clark Fork Valley Press & Mineral Independent, Plains, Mont. via Yahoo News· 3 days agoMay 8—Scheduling important medical appointments and arranging vital procedures can be a challenge living out in rural Montana. Hospitals and clinics are spread few and far between the mountainous ...
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
Chicago Sun-Times· 1 day agoWhen doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the drug that July.
